Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 April 2024 | Story Anthony Mthembu | Photo Francois van Vuuren
Varsity Cup Shimlas
The FNB UFS Shimlas are confident to emerge victorious as they prepare to go against the FNB UCT Ikeys in FNB Varsity Cup final.

The FNB UFS Shimlas are confident of securing a win in the 2024 FNB Varsity Cup final as they prepare to take on the FNB UCT Ikeys at the University of the Free State (UFS) Shimla Park in Bloemfontein on 22 April 2024 at 19:00. 

This marks the first time since 2015 that the final is being hosted at Shimla Park. As such, the Shimlas hope to use this home ground advantage to emerge victorious.

Prof Francis Petersen, Vice-Chancellor and Principal of the UFS, says he commends each player for their dedication, resilience, and sportsmanship throughout the season. “I will be cheering on the team – their efforts and commitment have already made us proud, and we look forward to supporting them on home ground. We are also immensely grateful to the coaching team for their support to the Shimlas. Good luck to the team, and know that every fellow Kovsie is behind you,” says Prof Petersen.

The Shimlas advanced to the final after a 38-24 win over the FNB Maties in the semi-finals held at the Danie Craven Stadium in Stellenbosch on 15 April 2024. According to André Tredoux, Head Coach of the FNB UFS Shimlas, this is a tremendous win for the team, as the FNB Maties have only lost ten times in the history of the FNB Varsity Cup when playing at home. In addition, he credits Assistant Coaches Melusi Mthethwa and Tiaan Liebenberg’s hard work for the success of the team up to this point.

The mindset of the UFS Shimlas heading into the final

According to Tredoux, the team assumes a new approach and mindset in preparation for each game. In the semi-finals, the team adopted the motto ‘breathe to succeed’, which helped align the focus and attitude of the team in the game. However, as the final approaches, he indicates that, “The big thing going into a final is to stick to our processes with our intensity, and then also for the medical team and the strength and conditioning team to get the team healthy”.

In addition, Tredoux encourages the UFS community to show up in their numbers to support the FNB UFS Shimlas. “The technical team will have a good plan and the players are ready to play with everything for the Cup. We have the firepower to do it with the support of the Kovsie students,” Tredoux expressed. He also highlights that those in attendance can expect a great atmosphere and some ‘awesome rugby’. This is because the FNB UFS Young Guns will also battle the FNB NWU Young Guns at Shimla Park on 22 April 2024 from 15:30.

Those interested in seeing any of this action can still purchase their tickets on the Varsity Cup website here

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept